Search Results

There are 95375 results for: content related to: Commentary

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  3. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  4. Abstracts of The Movement Disorder Society's Twelfth International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 23, Issue S1, 15 May 2008, Pages: S1–S422,

    Version of Record online : 28 MAY 2008, DOI: 10.1002/mds.22133

  5. Levodopa: Effect on cell death and the natural history of Parkinson's disease

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 37–44, C. Warren Olanow

    Version of Record online : 11 DEC 2014, DOI: 10.1002/mds.26119

  6. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study

    Movement Disorders

    Volume 21, Issue 3, March 2006, Pages: 343–353, Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer and Johannes Schwarz

    Version of Record online : 6 OCT 2005, DOI: 10.1002/mds.20724

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  8. Clinical spectrum of levodopa-induced complications

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 80–89, Camila Catherine Aquino and Susan H. Fox

    Version of Record online : 8 DEC 2014, DOI: 10.1002/mds.26125

  9. Poster session 2: Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S65–S114,

    Version of Record online : 21 OCT 2002, DOI: 10.1002/mds.10350

  10. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  11. You have free access to this content
    Abstracts of The Movement Disorder Society's Eleventh International Congress of Parkinson's Disease and Movement Disorders

    Movement Disorders

    Volume 22, Issue S16, 2007, Pages: S1–S325,

    Version of Record online : 24 APR 2007, DOI: 10.1002/mds.21535

  12. Chronic l-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

    European Journal of Neuroscience

    Volume 20, Issue 5, September 2004, Pages: 1255–1266, S. Robelet, C. Melon, B. Guillet, P. Salin and L. Kerkerian-Le Goff

    Version of Record online : 18 AUG 2004, DOI: 10.1111/j.1460-9568.2004.03591.x

  13. Novel formulations and modes of delivery of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 114–120, Werner Poewe and Angelo Antonini

    Version of Record online : 5 DEC 2014, DOI: 10.1002/mds.26078

  14. You have free access to this content
    Unpredictable Rotational Responses to L-dopa in the Rat Model of Parkinson’s Disease: the Role of L-dopa Pharmacokinetics and Striatal Dopamine Depletion

    Basic & Clinical Pharmacology & Toxicology

    Volume 110, Issue 2, February 2012, Pages: 162–170, Tiina M. Kääriäinen, Mikko Käenmäki, Markus M. Forsberg, Niko Oinas, Anne Tammimäki and Pekka T. Männistö

    Version of Record online : 13 SEP 2011, DOI: 10.1111/j.1742-7843.2011.00782.x

  15. You have free access to this content
    Dopamine depletion and subsequent treatment with l-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum

    Journal of Neurochemistry

    Volume 102, Issue 3, August 2007, Pages: 699–711, Evgeny Bychkov, M. Rafiuddin Ahmed, Kevin N. Dalby and Eugenia V. Gurevich

    Version of Record online : 21 MAR 2007, DOI: 10.1111/j.1471-4159.2007.04586.x

  16. Levodopa in the treatment of Parkinson's disease: Current controversies

    Movement Disorders

    Volume 19, Issue 9, September 2004, Pages: 997–1005, C. Warren Olanow, Yves Agid, Yoshi Mizuno, Alberto Albanese, U. Bonucelli, Philip Damier, Justo De Yebenes, Oscar Gershanik, Mark Guttman, F. Grandas, Mark Hallett, Ole Hornykiewicz, Peter Jenner, R. Katzenschlager, William J. Langston, Peter LeWitt, Eldad Melamed, M.A. Mena, P.P. Michel, Catherine Mytilineou, Jose A. Obeso, Werner Poewe, Niall Quinn, R. Raisman-Vozari, Ali H. Rajput, Olivier Rascol, Christina Sampaio and Fabrizio Stocchi

    Version of Record online : 30 JUL 2004, DOI: 10.1002/mds.20243

  17. Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitizing motor behaviours

    European Journal of Neuroscience

    Volume 21, Issue 1, January 2005, Pages: 179–186, E. L. Lane, S. C. Cheetham and P. Jenner

    Version of Record online : 12 JAN 2005, DOI: 10.1111/j.1460-9568.2004.03834.x

  18. New treatments for levodopa-induced motor complications

    Movement Disorders

    Volume 30, Issue 11, 15 September 2015, Pages: 1451–1460, Olivier Rascol, Santiago Perez-Lloret and Joaquim J Ferreira

    Version of Record online : 21 AUG 2015, DOI: 10.1002/mds.26362

  19. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 19–36, Andrew J. Lees, Eduardo Tolosa and C. Warren Olanow

    Version of Record online : 8 DEC 2014, DOI: 10.1002/mds.26120

  20. You have free access to this content
    Effect of l-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys

    Journal of Neurochemistry

    Volume 113, Issue 3, May 2010, Pages: 715–724, Bazoumana Ouattara, Fabrizio Gasparini, Marc Morissette, Laurent Grégoire, Pershia Samadi, Baltazar Gomez-Mancilla and Thérèse Di Paolo

    Version of Record online : 1 FEB 2010, DOI: 10.1111/j.1471-4159.2010.06635.x